A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease

Lack of Sustained Improvement in Adherence or Viral Load Following a Directly Observed Antiretroviral Therapy Intervention

(2011) K. M. Berg et al.   CLINICAL INFECTIOUS DISEASES

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

(2011) Winfred C Wang et al.   LANCET

Redesigning Employee Health Incentives — Lessons from Behavioral Economics

(2011) Kevin G. Volpp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen

(2011) Ines Paule et al.   Orphanet Journal of Rare Diseases

Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease

(2010) Sean D. Candrilli et al.   AMERICAN JOURNAL OF HEMATOLOGY

Improving the measurement of self-reported medication nonadherence: Response to Authors

(2010) Donald E. Morisky et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

(2009) Murtuza Bharmal et al.   Health and Quality of Life Outcomes

Adherence to Hydroxyurea Therapy in Children with Sickle Cell Anemia

(2009) Courtney D. Thornburg et al.   JOURNAL OF PEDIATRICS